Mark Burcin

3.3k total citations · 1 hit paper
23 papers, 2.3k citations indexed

About

Mark Burcin is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Mark Burcin has authored 23 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Surgery. Recurrent topics in Mark Burcin's work include Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (6 papers) and Pancreatic function and diabetes (5 papers). Mark Burcin is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), CRISPR and Genetic Engineering (6 papers) and Pancreatic function and diabetes (5 papers). Mark Burcin collaborates with scholars based in United States, Switzerland and Germany. Mark Burcin's co-authors include Bert W. O’Malley, Sophia Y. Tsai, Guido Jenster, Thomas E. Spencer, Ming‐Jer Tsai, Jianxin Zhou, Craig A. Mizzen, Neil J. McKenna, Sergio A. Oñate and C. David Allis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Mark Burcin

23 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Steroid receptor coactivator-1 is a histone acetyltransferase

1997 1.0k citations Thomas E. Spencer, Guido Jenster et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Burcin United States	14	1.6k	1.1k	317	260	250	23	2.3k
Bryan D. Lemon United States	21	2.3k 1.4×	718 0.7×	130 0.4×	152 0.6×	358 1.4×	34	3.1k
Chao‐Xing Yuan United States	16	1.9k 1.1×	601 0.6×	118 0.4×	173 0.7×	325 1.3×	25	2.3k
Robert J.G. Haché Canada	30	1.8k 1.1×	773 0.7×	103 0.3×	370 1.4×	457 1.8×	55	2.6k
Martin Dutertre France	31	2.4k 1.5×	876 0.8×	69 0.2×	186 0.7×	351 1.4×	47	3.2k
Susan Zollman United States	19	1.1k 0.7×	527 0.5×	232 0.7×	226 0.9×	157 0.6×	21	1.9k
Benoît Bilanges United Kingdom	20	2.0k 1.2×	300 0.3×	261 0.8×	98 0.4×	378 1.5×	27	2.9k
Lee Carpenter United Kingdom	26	1.7k 1.0×	286 0.3×	494 1.6×	243 0.9×	322 1.3×	36	2.4k
Mireille Vasseur-Cognet France	23	1.2k 0.8×	397 0.4×	604 1.9×	168 0.6×	148 0.6×	41	1.9k
Torkel Vang Norway	24	1.6k 1.0×	799 0.7×	286 0.9×	243 0.9×	420 1.7×	39	3.0k
Elora J. Weringer United States	12	1.1k 0.7×	356 0.3×	317 1.0×	258 1.0×	344 1.4×	14	2.3k

Countries citing papers authored by Mark Burcin

Since Specialization

Citations

This map shows the geographic impact of Mark Burcin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Burcin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Burcin more than expected).

Fields of papers citing papers by Mark Burcin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Burcin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Burcin. The network helps show where Mark Burcin may publish in the future.

Co-authorship network of co-authors of Mark Burcin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Burcin. A scholar is included among the top collaborators of Mark Burcin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Burcin. Mark Burcin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doijen, Jordi, Inha Heo, Koen Temmerman, et al.. (2023). A flexible, image-based, high-throughput platform encompassing in-depth cell profiling to identify broad-spectrum coronavirus antivirals with limited off-target effects. Antiviral Research. 222. 105789–105789. 1 indexed citations

Roudnicky, Filip, Bo Kyoung Kim, Roland Schmucki, et al.. (2020). Identification of a combination of transcription factors that synergistically increases endothelial cell barrier resistance. Scientific Reports. 10(1). 3886–3886. 34 indexed citations

Cader, M. Zameel, Martin Graf, Mark Burcin, Carl‐Fredrik Mandenius, & James A. Ross. (2019). Cell-Based Assays Using Differentiated Human Induced Pluripotent Cells. Methods in molecular biology. 1994. 1–14. 9 indexed citations

Zoffmann, Sannah, Maarten Vercruysse, Fethallah Benmansour, et al.. (2019). Machine learning-powered antibiotics phenotypic drug discovery. Scientific Reports. 9(1). 5013–5013. 67 indexed citations

Christensen, Klaus, Filip Roudnicky, Mark Burcin, & Christoph Patsch. (2019). Monolayer Generation of Vascular Endothelial Cells from Human Pluripotent Stem Cells. Methods in molecular biology. 1994. 17–29. 8 indexed citations

Roudnicky, Filip, Max Friesen, Gregor Dernick, et al.. (2019). Modeling the Effects of Severe Metabolic Disease by Genome Editing of hPSC-Derived Endothelial Cells Reveals an Inflammatory Phenotype. International Journal of Molecular Sciences. 20(24). 6201–6201. 3 indexed citations

Meyer, Claas A., Stefan Aigner, Klaus Christensen, et al.. (2017). Generation of a homozygous GBA deletion human embryonic stem cell line. Stem Cell Research. 23. 122–126. 3 indexed citations

Christensen, Klaus, Filip Roudnicky, Christoph Patsch, & Mark Burcin. (2017). Requirements for Using iPSC-Based Cell Models for Assay Development in Drug Discovery. Advances in biochemical engineering, biotechnology. 163. 207–220. 7 indexed citations

Fonseca, Sonya G., Fumihiko Urano, Mark Burcin, & Jesper Gromada. (2010). Stress hypERactivation in the β-cell. Islets. 2(1). 1–9. 55 indexed citations

10.

Fonseca, Sonya G., Mark Burcin, Jesper Gromada, & Fumihiko Urano. (2009). Endoplasmic reticulum stress in β-cells and development of diabetes. Current Opinion in Pharmacology. 9(6). 763–770. 132 indexed citations

11.

Jones, Jordan, et al.. (2004). In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia. 47(8). 1442–51. 132 indexed citations

12.

Roche, Enrique, Mark Burcin, Sybille Esser, Manfred Rüdiger, & Bernat Soria. (2003). The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells. Cytotechnology. 41(2-3). 145–151. 7 indexed citations

13.

Schillinger, Kurt J., et al.. (2002). [31] Ligand-inducible transgene regulation for gene therapy. Methods in enzymology on CD-ROM/Methods in enzymology. 346. 551–561. 15 indexed citations

14.

Zhao, Bihong, Susan Magdaleno, Steven S. Chua, et al.. (2000). TRANSGENIC MOUSE MODELS FOR LUNG CANCER. Experimental Lung Research. 26(8). 567–579. 10 indexed citations

15.

Abruzzese, Ronald V., Mark Burcin, Vidya Mehta, et al.. (1999). Ligand-Dependent Regulation of Plasmid-Based Transgene Expression in Vivo. Human Gene Therapy. 10(9). 1499–1507. 47 indexed citations

16.

Burcin, Mark, Gudrun Schiedner, Stefan Kochanek, Sophia Y. Tsai, & Bert W. O’Malley. (1999). Adenovirus-mediated regulable target gene expression in vivo. Proceedings of the National Academy of Sciences. 96(2). 355–360. 201 indexed citations

17.

Spencer, Thomas E., Guido Jenster, Mark Burcin, et al.. (1997). Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389(6647). 194–198. 1028 indexed citations breakdown →

18.

Burcin, Mark, Rüdiger Arnold, M. Lutz, et al.. (1997). Negative Protein 1, Which Is Required for Function of the Chicken Lysozyme Gene Silencer in Conjunction with Hormone Receptors, Is Identical to the Multivalent Zinc Finger Repressor CTCF. Molecular and Cellular Biology. 17(3). 1281–1288. 116 indexed citations

19.

Jenster, Guido, Thomas E. Spencer, Mark Burcin, et al.. (1997). Steroid receptor induction of gene transcription: A two-step model. Proceedings of the National Academy of Sciences. 94(15). 7879–7884. 233 indexed citations

20.

Arnold, Rüdiger, Mark Burcin, Brent N. Kaiser, Marc Müller, & Rainer Renkawitz. (1996). DNA Bending by the Silencer Protein NeP1 Is Modulated by TR and RXR. Nucleic Acids Research. 24(14). 2640–2647. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact